Summary

The global Adeno-Associated Virus (AAV) Vector Production CDMO market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Adeno-Associated Virus (AAV) Vector Production CDMO (Contract Development and Manufacturing Organization) refers to companies that specialize in the development and large-scale production of AAV vectors, which are commonly used as gene therapy delivery systems. CDMOs provide a range of services including vector design, process development, scale-up, manufacturing, and quality control under Good Manufacturing Practices (GMP) standards. These organizations support biotechnology and pharmaceutical companies by producing clinical-grade AAV vectors for preclinical research, clinical trials, and commercial use, helping to meet the growing demand for gene therapies.
United States market for Adeno-Associated Virus (AAV) Vector Production CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Adeno-Associated Virus (AAV) Vector Production CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Adeno-Associated Virus (AAV) Vector Production CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Adeno-Associated Virus (AAV) Vector Production CDMO players cover Thermo Fisher Scientific, Lonza, Catalent, Charles River, Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Adeno-Associated Virus (AAV) Vector Production CDMO Industry Forecast” looks at past sales and reviews total world Adeno-Associated Virus (AAV) Vector Production CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Adeno-Associated Virus (AAV) Vector Production CDMO sales for 2026 through 2032. With Adeno-Associated Virus (AAV) Vector Production CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adeno-Associated Virus (AAV) Vector Production CDMO industry.
This Insight Report provides a comprehensive analysis of the global Adeno-Associated Virus (AAV) Vector Production CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Adeno-Associated Virus (AAV) Vector Production CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Adeno-Associated Virus (AAV) Vector Production CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adeno-Associated Virus (AAV) Vector Production CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adeno-Associated Virus (AAV) Vector Production CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Adeno-Associated Virus (AAV) Vector Production CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
Adherent Culture
Suspension Culture
Segmentation by Application:
Vaccine Development
Gene Therapy
Academic Scientific Research Institution
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Lonza
Catalent
Charles River
Merck
SK pharmteco
Oxford Biomedica
AGC Biologics（MolMed）
Gene Universal
Polyplus (Sartorius)
CCRM
FUJIFILM Diosynth Biotechnologies
Biovian
Miltenyi Bioindustry
Aldevron
Takara Bio
Yposkesi
Genezen
Exthera
GenScript ProBio
EurekaBio
Obio Technology
GeneSail Biotech
VectorBuilder
WuXi ATU
Ubrigene
Porton Biologics
Pharmaron
PackGene Biotechnology

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size (2021-2032)
2.1.2 Adeno-Associated Virus (AAV) Vector Production CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Adeno-Associated Virus (AAV) Vector Production CDMO by Country/Region (2021, 2025 & 2032)
2.2 Adeno-Associated Virus (AAV) Vector Production CDMO Segment by Type
2.2.1 Adherent Culture
2.2.2 Suspension Culture
2.2.3 Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Type
2.2.3.1 Adeno-Associated Virus (AAV) Vector Production CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Type (2021-2026)
2.3 Adeno-Associated Virus (AAV) Vector Production CDMO Segment by Application
2.3.1 Vaccine Development
2.3.2 Gene Therapy
2.3.3 Academic Scientific Research Institution
2.3.4 Others
2.3.5 Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Application
2.3.5.1 Adeno-Associated Virus (AAV) Vector Production CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Application (2021-2026)
3 Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Player
3.1 Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Player
3.1.1 Global Adeno-Associated Virus (AAV) Vector Production CDMO Revenue by Player (2021-2026)
3.1.2 Global Adeno-Associated Virus (AAV) Vector Production CDMO Revenue Market Share by Player (2021-2026)
3.2 Global Adeno-Associated Virus (AAV) Vector Production CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Adeno-Associated Virus (AAV) Vector Production CDMO by Region
4.1 Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Region (2021-2026)
4.2 Global Adeno-Associated Virus (AAV) Vector Production CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth (2021-2026)
4.4 APAC Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth (2021-2026)
4.5 Europe Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth (2021-2026)
5 Americas
5.1 Americas Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Country (2021-2026)
5.2 Americas Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Type (2021-2026)
5.3 Americas Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Region (2021-2026)
6.2 APAC Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Type (2021-2026)
6.3 APAC Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Country (2021-2026)
7.2 Europe Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Type (2021-2026)
7.3 Europe Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Adeno-Associated Virus (AAV) Vector Production CDMO by Region (2021-2026)
8.2 Middle East & Africa Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Forecast
10.1 Global Adeno-Associated Virus (AAV) Vector Production CDMO Forecast by Region (2027-2032)
10.1.1 Global Adeno-Associated Virus (AAV) Vector Production CDMO Forecast by Region (2027-2032)
10.1.2 Americas Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.1.3 APAC Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.1.4 Europe Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.1.5 Middle East & Africa Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.2 Americas Adeno-Associated Virus (AAV) Vector Production CDMO Forecast by Country (2027-2032)
10.2.1 United States Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.2.2 Canada Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.2.3 Mexico Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.2.4 Brazil Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.3 APAC Adeno-Associated Virus (AAV) Vector Production CDMO Forecast by Region (2027-2032)
10.3.1 China Adeno-Associated Virus (AAV) Vector Production CDMO Market Forecast
10.3.2 Japan Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.3.3 Korea Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.3.4 Southeast Asia Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.3.5 India Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.3.6 Australia Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.4 Europe Adeno-Associated Virus (AAV) Vector Production CDMO Forecast by Country (2027-2032)
10.4.1 Germany Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.4.2 France Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.4.3 UK Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.4.4 Italy Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.4.5 Russia Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.5 Middle East & Africa Adeno-Associated Virus (AAV) Vector Production CDMO Forecast by Region (2027-2032)
10.5.1 Egypt Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.5.2 South Africa Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.5.3 Israel Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.5.4 Turkey Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
10.6 Global Adeno-Associated Virus (AAV) Vector Production CDMO Forecast by Type (2027-2032)
10.7 Global Adeno-Associated Virus (AAV) Vector Production CDMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Adeno-Associated Virus (AAV) Vector Production CDMO Forecast
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.1.3 Thermo Fisher Scientific Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Lonza
11.2.1 Lonza Company Information
11.2.2 Lonza Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.2.3 Lonza Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Lonza Main Business Overview
11.2.5 Lonza Latest Developments
11.3 Catalent
11.3.1 Catalent Company Information
11.3.2 Catalent Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.3.3 Catalent Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Catalent Main Business Overview
11.3.5 Catalent Latest Developments
11.4 Charles River
11.4.1 Charles River Company Information
11.4.2 Charles River Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.4.3 Charles River Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Charles River Main Business Overview
11.4.5 Charles River Latest Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.5.3 Merck Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Merck Main Business Overview
11.5.5 Merck Latest Developments
11.6 SK pharmteco
11.6.1 SK pharmteco Company Information
11.6.2 SK pharmteco Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.6.3 SK pharmteco Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 SK pharmteco Main Business Overview
11.6.5 SK pharmteco Latest Developments
11.7 Oxford Biomedica
11.7.1 Oxford Biomedica Company Information
11.7.2 Oxford Biomedica Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.7.3 Oxford Biomedica Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Oxford Biomedica Main Business Overview
11.7.5 Oxford Biomedica Latest Developments
11.8 AGC Biologics（MolMed）
11.8.1 AGC Biologics（MolMed） Company Information
11.8.2 AGC Biologics（MolMed） Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.8.3 AGC Biologics（MolMed） Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 AGC Biologics（MolMed） Main Business Overview
11.8.5 AGC Biologics（MolMed） Latest Developments
11.9 Gene Universal
11.9.1 Gene Universal Company Information
11.9.2 Gene Universal Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.9.3 Gene Universal Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Gene Universal Main Business Overview
11.9.5 Gene Universal Latest Developments
11.10 Polyplus (Sartorius)
11.10.1 Polyplus (Sartorius) Company Information
11.10.2 Polyplus (Sartorius) Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.10.3 Polyplus (Sartorius) Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Polyplus (Sartorius) Main Business Overview
11.10.5 Polyplus (Sartorius) Latest Developments
11.11 CCRM
11.11.1 CCRM Company Information
11.11.2 CCRM Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.11.3 CCRM Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 CCRM Main Business Overview
11.11.5 CCRM Latest Developments
11.12 FUJIFILM Diosynth Biotechnologies
11.12.1 FUJIFILM Diosynth Biotechnologies Company Information
11.12.2 FUJIFILM Diosynth Biotechnologies Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.12.3 FUJIFILM Diosynth Biotechnologies Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.12.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.13 Biovian
11.13.1 Biovian Company Information
11.13.2 Biovian Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.13.3 Biovian Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Biovian Main Business Overview
11.13.5 Biovian Latest Developments
11.14 Miltenyi Bioindustry
11.14.1 Miltenyi Bioindustry Company Information
11.14.2 Miltenyi Bioindustry Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.14.3 Miltenyi Bioindustry Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Miltenyi Bioindustry Main Business Overview
11.14.5 Miltenyi Bioindustry Latest Developments
11.15 Aldevron
11.15.1 Aldevron Company Information
11.15.2 Aldevron Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.15.3 Aldevron Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Aldevron Main Business Overview
11.15.5 Aldevron Latest Developments
11.16 Takara Bio
11.16.1 Takara Bio Company Information
11.16.2 Takara Bio Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.16.3 Takara Bio Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Takara Bio Main Business Overview
11.16.5 Takara Bio Latest Developments
11.17 Yposkesi
11.17.1 Yposkesi Company Information
11.17.2 Yposkesi Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.17.3 Yposkesi Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Yposkesi Main Business Overview
11.17.5 Yposkesi Latest Developments
11.18 Genezen
11.18.1 Genezen Company Information
11.18.2 Genezen Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.18.3 Genezen Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Genezen Main Business Overview
11.18.5 Genezen Latest Developments
11.19 Exthera
11.19.1 Exthera Company Information
11.19.2 Exthera Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.19.3 Exthera Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Exthera Main Business Overview
11.19.5 Exthera Latest Developments
11.20 GenScript ProBio
11.20.1 GenScript ProBio Company Information
11.20.2 GenScript ProBio Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.20.3 GenScript ProBio Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 GenScript ProBio Main Business Overview
11.20.5 GenScript ProBio Latest Developments
11.21 EurekaBio
11.21.1 EurekaBio Company Information
11.21.2 EurekaBio Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.21.3 EurekaBio Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 EurekaBio Main Business Overview
11.21.5 EurekaBio Latest Developments
11.22 Obio Technology
11.22.1 Obio Technology Company Information
11.22.2 Obio Technology Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.22.3 Obio Technology Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Obio Technology Main Business Overview
11.22.5 Obio Technology Latest Developments
11.23 GeneSail Biotech
11.23.1 GeneSail Biotech Company Information
11.23.2 GeneSail Biotech Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.23.3 GeneSail Biotech Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 GeneSail Biotech Main Business Overview
11.23.5 GeneSail Biotech Latest Developments
11.24 VectorBuilder
11.24.1 VectorBuilder Company Information
11.24.2 VectorBuilder Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.24.3 VectorBuilder Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 VectorBuilder Main Business Overview
11.24.5 VectorBuilder Latest Developments
11.25 WuXi ATU
11.25.1 WuXi ATU Company Information
11.25.2 WuXi ATU Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.25.3 WuXi ATU Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 WuXi ATU Main Business Overview
11.25.5 WuXi ATU Latest Developments
11.26 Ubrigene
11.26.1 Ubrigene Company Information
11.26.2 Ubrigene Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.26.3 Ubrigene Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 Ubrigene Main Business Overview
11.26.5 Ubrigene Latest Developments
11.27 Porton Biologics
11.27.1 Porton Biologics Company Information
11.27.2 Porton Biologics Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.27.3 Porton Biologics Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 Porton Biologics Main Business Overview
11.27.5 Porton Biologics Latest Developments
11.28 Pharmaron
11.28.1 Pharmaron Company Information
11.28.2 Pharmaron Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.28.3 Pharmaron Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 Pharmaron Main Business Overview
11.28.5 Pharmaron Latest Developments
11.29 PackGene Biotechnology
11.29.1 PackGene Biotechnology Company Information
11.29.2 PackGene Biotechnology Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
11.29.3 PackGene Biotechnology Adeno-Associated Virus (AAV) Vector Production CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.29.4 PackGene Biotechnology Main Business Overview
11.29.5 PackGene Biotechnology Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Adeno-Associated Virus (AAV) Vector Production CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Adeno-Associated Virus (AAV) Vector Production CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Adherent Culture
Table 4. Major Players of Suspension Culture
Table 5. Adeno-Associated Virus (AAV) Vector Production CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Type (2021-2026)
Table 8. Adeno-Associated Virus (AAV) Vector Production CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Application (2021-2026)
Table 11. Global Adeno-Associated Virus (AAV) Vector Production CDMO Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Adeno-Associated Virus (AAV) Vector Production CDMO Revenue Market Share by Player (2021-2026)
Table 13. Adeno-Associated Virus (AAV) Vector Production CDMO Key Players Head office and Products Offered
Table 14. Adeno-Associated Virus (AAV) Vector Production CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Region (2021-2026)
Table 19. Global Adeno-Associated Virus (AAV) Vector Production CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Adeno-Associated Virus (AAV) Vector Production CDMO Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Country (2021-2026)
Table 23. Americas Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Type (2021-2026)
Table 25. Americas Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Application (2021-2026)
Table 27. APAC Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Region (2021-2026)
Table 29. APAC Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Country (2021-2026)
Table 33. Europe Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Adeno-Associated Virus (AAV) Vector Production CDMO Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Adeno-Associated Virus (AAV) Vector Production CDMO
Table 39. Key Market Challenges & Risks of Adeno-Associated Virus (AAV) Vector Production CDMO
Table 40. Key Industry Trends of Adeno-Associated Virus (AAV) Vector Production CDMO
Table 41. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Thermo Fisher Scientific Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 46. Thermo Fisher Scientific Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 47. Thermo Fisher Scientific Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Thermo Fisher Scientific Main Business
Table 49. Thermo Fisher Scientific Latest Developments
Table 50. Lonza Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 51. Lonza Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 52. Lonza Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Lonza Main Business
Table 54. Lonza Latest Developments
Table 55. Catalent Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 56. Catalent Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 57. Catalent Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Catalent Main Business
Table 59. Catalent Latest Developments
Table 60. Charles River Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 61. Charles River Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 62. Charles River Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Charles River Main Business
Table 64. Charles River Latest Developments
Table 65. Merck Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 66. Merck Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 67. Merck Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Merck Main Business
Table 69. Merck Latest Developments
Table 70. SK pharmteco Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 71. SK pharmteco Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 72. SK pharmteco Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. SK pharmteco Main Business
Table 74. SK pharmteco Latest Developments
Table 75. Oxford Biomedica Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 76. Oxford Biomedica Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 77. Oxford Biomedica Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Oxford Biomedica Main Business
Table 79. Oxford Biomedica Latest Developments
Table 80. AGC Biologics（MolMed） Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 81. AGC Biologics（MolMed） Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 82. AGC Biologics（MolMed） Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. AGC Biologics（MolMed） Main Business
Table 84. AGC Biologics（MolMed） Latest Developments
Table 85. Gene Universal Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 86. Gene Universal Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 87. Gene Universal Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Gene Universal Main Business
Table 89. Gene Universal Latest Developments
Table 90. Polyplus (Sartorius) Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 91. Polyplus (Sartorius) Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 92. Polyplus (Sartorius) Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Polyplus (Sartorius) Main Business
Table 94. Polyplus (Sartorius) Latest Developments
Table 95. CCRM Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 96. CCRM Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 97. CCRM Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. CCRM Main Business
Table 99. CCRM Latest Developments
Table 100. FUJIFILM Diosynth Biotechnologies Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 101. FUJIFILM Diosynth Biotechnologies Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 102. FUJIFILM Diosynth Biotechnologies Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. FUJIFILM Diosynth Biotechnologies Main Business
Table 104. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 105. Biovian Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 106. Biovian Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 107. Biovian Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Biovian Main Business
Table 109. Biovian Latest Developments
Table 110. Miltenyi Bioindustry Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 111. Miltenyi Bioindustry Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 112. Miltenyi Bioindustry Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Miltenyi Bioindustry Main Business
Table 114. Miltenyi Bioindustry Latest Developments
Table 115. Aldevron Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 116. Aldevron Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 117. Aldevron Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Aldevron Main Business
Table 119. Aldevron Latest Developments
Table 120. Takara Bio Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 121. Takara Bio Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 122. Takara Bio Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Takara Bio Main Business
Table 124. Takara Bio Latest Developments
Table 125. Yposkesi Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 126. Yposkesi Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 127. Yposkesi Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Yposkesi Main Business
Table 129. Yposkesi Latest Developments
Table 130. Genezen Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 131. Genezen Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 132. Genezen Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Genezen Main Business
Table 134. Genezen Latest Developments
Table 135. Exthera Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 136. Exthera Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 137. Exthera Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Exthera Main Business
Table 139. Exthera Latest Developments
Table 140. GenScript ProBio Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 141. GenScript ProBio Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 142. GenScript ProBio Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. GenScript ProBio Main Business
Table 144. GenScript ProBio Latest Developments
Table 145. EurekaBio Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 146. EurekaBio Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 147. EurekaBio Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. EurekaBio Main Business
Table 149. EurekaBio Latest Developments
Table 150. Obio Technology Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 151. Obio Technology Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 152. Obio Technology Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 153. Obio Technology Main Business
Table 154. Obio Technology Latest Developments
Table 155. GeneSail Biotech Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 156. GeneSail Biotech Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 157. GeneSail Biotech Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 158. GeneSail Biotech Main Business
Table 159. GeneSail Biotech Latest Developments
Table 160. VectorBuilder Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 161. VectorBuilder Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 162. VectorBuilder Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 163. VectorBuilder Main Business
Table 164. VectorBuilder Latest Developments
Table 165. WuXi ATU Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 166. WuXi ATU Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 167. WuXi ATU Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 168. WuXi ATU Main Business
Table 169. WuXi ATU Latest Developments
Table 170. Ubrigene Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 171. Ubrigene Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 172. Ubrigene Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 173. Ubrigene Main Business
Table 174. Ubrigene Latest Developments
Table 175. Porton Biologics Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 176. Porton Biologics Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 177. Porton Biologics Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 178. Porton Biologics Main Business
Table 179. Porton Biologics Latest Developments
Table 180. Pharmaron Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 181. Pharmaron Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 182. Pharmaron Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 183. Pharmaron Main Business
Table 184. Pharmaron Latest Developments
Table 185. PackGene Biotechnology Details, Company Type, Adeno-Associated Virus (AAV) Vector Production CDMO Area Served and Its Competitors
Table 186. PackGene Biotechnology Adeno-Associated Virus (AAV) Vector Production CDMO Product Offered
Table 187. PackGene Biotechnology Adeno-Associated Virus (AAV) Vector Production CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 188. PackGene Biotechnology Main Business
Table 189. PackGene Biotechnology Latest Developments


List of Figures
Figure 1. Adeno-Associated Virus (AAV) Vector Production CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Adeno-Associated Virus (AAV) Vector Production CDMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Adeno-Associated Virus (AAV) Vector Production CDMO Sales Market Share by Country/Region (2025)
Figure 8. Adeno-Associated Virus (AAV) Vector Production CDMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Type in 2025
Figure 10. Adeno-Associated Virus (AAV) Vector Production CDMO in Vaccine Development
Figure 11. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market: Vaccine Development (2021-2026) & ($ millions)
Figure 12. Adeno-Associated Virus (AAV) Vector Production CDMO in Gene Therapy
Figure 13. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market: Gene Therapy (2021-2026) & ($ millions)
Figure 14. Adeno-Associated Virus (AAV) Vector Production CDMO in Academic Scientific Research Institution
Figure 15. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market: Academic Scientific Research Institution (2021-2026) & ($ millions)
Figure 16. Adeno-Associated Virus (AAV) Vector Production CDMO in Others
Figure 17. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market: Others (2021-2026) & ($ millions)
Figure 18. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Application in 2025
Figure 19. Global Adeno-Associated Virus (AAV) Vector Production CDMO Revenue Market Share by Player in 2025
Figure 20. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Region (2021-2026)
Figure 21. Americas Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2021-2026 ($ millions)
Figure 22. APAC Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2021-2026 ($ millions)
Figure 23. Europe Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2021-2026 ($ millions)
Figure 25. Americas Adeno-Associated Virus (AAV) Vector Production CDMO Value Market Share by Country in 2025
Figure 26. United States Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Region in 2025
Figure 31. APAC Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Type (2021-2026)
Figure 32. APAC Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Application (2021-2026)
Figure 33. China Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 37. India Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Country in 2025
Figure 40. Europe Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Type (2021-2026)
Figure 41. Europe Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Application (2021-2026)
Figure 42. Germany Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 43. France Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 56. APAC Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 57. Europe Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 59. United States Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 60. Canada Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 61. Mexico Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 62. Brazil Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 63. China Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 64. Japan Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 65. Korea Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 67. India Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 68. Australia Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 69. Germany Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 70. France Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 71. UK Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 72. Italy Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 73. Russia Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 74. Egypt Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 75. South Africa Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 76. Israel Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 77. Turkey Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)
Figure 78. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Adeno-Associated Virus (AAV) Vector Production CDMO Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Adeno-Associated Virus (AAV) Vector Production CDMO Market Size 2027-2032 ($ millions)